Articulo Cientifico 10.3390@polym12091962
Articulo Cientifico 10.3390@polym12091962
Article
3D Printed Polycaprolactone/Gelatin/Bacterial
Cellulose/Hydroxyapatite Composite Scaffold for
Bone Tissue Engineering
Abdullah M. Cakmak 1,2 , Semra Unal 1,2,3 , Ali Sahin 4 , Faik N. Oktar 1,2 , Mustafa Sengor 2,5 ,
Nazmi Ekren 2,6 , Oguzhan Gunduz 2,5, * and Deepak M. Kalaskar 7, *
1 Department of Bioengineering, Faculty of Engineering, Marmara University, 34722 Istanbul, Turkey;
[email protected] (A.M.C.); [email protected] (S.U.);
[email protected] (F.N.O.)
2 Center for Nanotechnology & Biomaterials Application and Research (NBUAM), Marmara University,
34722 Istanbul, Turkey; [email protected] (M.S.); [email protected] (N.E.)
3 Institute of Neurological Sciences, Marmara University, 34722 Istanbul, Turkey
4 Department of Biochemistry, School of Medicine/Genetic and Metabolic Diseases Research and
Investigation Center, Marmara University, 34722 Istanbul, Turkey; [email protected]
5 Department of Metallurgy and Materials Engineering, Faculty of Technology, Marmara University,
34722 Istanbul, Turkey
6 Department of Electrical and Electronics Engineering, Faculty of Technology, Marmara University,
34722 Istanbul, Turkey
7 UCL Division of Surgery and Interventional Sciences, Royal Free Hospital Campus Rowland Hill Street,
London NW3 2PF, UK
* Correspondence: [email protected] (O.G.); [email protected] (D.M.K.)
Received: 28 July 2020; Accepted: 26 August 2020; Published: 29 August 2020
Abstract: Three-dimensional (3D) printing application is a promising method for bone tissue
engineering. For enhanced bone tissue regeneration, it is essential to have printable composite
materials with appealing properties such as construct porous, mechanical strength, thermal properties,
controlled degradation rates, and the presence of bioactive materials. In this study, polycaprolactone
(PCL), gelatin (GEL), bacterial cellulose (BC), and different hydroxyapatite (HA) concentrations were
used to fabricate a novel PCL/GEL/BC/HA composite scaffold using 3D printing method for bone
tissue engineering applications. Pore structure, mechanical, thermal, and chemical analyses were
evaluated. 3D scaffolds with an ideal pore size (~300 µm) for use in bone tissue engineering were
generated. The addition of both bacterial cellulose (BC) and hydroxyapatite (HA) into PCL/GEL
scaffold increased cell proliferation and attachment. PCL/GEL/BC/HA composite scaffolds provide a
potential for bone tissue engineering applications.
1. Introduction
The treatment approach to bone injury and degeneration remains a critical challenge,
although autografting continues as the clinical gold standard treatment option [1–3]. This led to
increased interest in tissue engineering and regenerative medicine, which offer a new perspective for
repairing bone defects. Natural bone is a heterogeneous composite material that consists of the orderly
deposition of hydroxyapatite (HA) along with the type I collagen (Col) organic matrix. According to
the biomimetic concept, an ideal 3D scaffold not only actively induces bone regeneration into desired
shapes but also plays a significant role to bridge in bone defects. Therefore, instead of a single-use of
natural (e.g., collagen, gelatin, alginate, hyaluronic acid, and chitosan) synthetic polymers (e.g., PLGA,
PLA, and polycaprolactone (PCL)) and bioceramics (the calcium phosphates (Ca/P) as hydroxyapatite
(HAp), the bioactive glasses and the glass-ceramics), composite forms of them have been widely
used for bone tissue engineering [4,5]. Compared with these natural materials, bacterial cellulose
nanocrystal (BC) has much higher mechanical properties, which are required in most cases when
used as a scaffold in bone tissue engineering There are remarkable features of bacterial cellulose that
make it applicable in bone tissue engineering: biocompatibility, promoting cellular interactions and
tissue development, having interconnected porous structure and significant effects on cell adhesion
and proliferation, high purity level, microporosity, biodegradability, bio-absorbable, non-toxicity,
resembling extracellular matrix of living tissue, and crystallinity [6–10].
Gelatin (Gel) is procured with denaturation of insoluble fibrous collagen protein. This denaturated
material does not show resorbability or antigenicity in vivo [11]. Some properties such as
low antigenicity, abundance, biocompatibility, accessible, functional groups, cost-effectiveness,
and biodegradability give regenerative, and therapeutic characteristics to gelatin [12,13]. PCL is a
synthetic, and semicrystalline polymer, that exhibits outstanding mechanical strength and appropriate
biodegradable properties. As a result that PCL is a hydrophobic polymer whereas BC and Gel are
hydrophilic, proper methods should be explored for uniformly mixing these natural and synthetic
polymers. Scaffolds by a manufacture with various processing methods are not intended to be
permanent implants. They will ideally facilitate host cells to deposit extracellular matrix (ECM) and
replace the scaffold structure over time.
The 3D architecture of the scaffold should be highly porous with an interconnected structure
to allow cell and nutrient migration. The scaffold surface should also be optimized to facilitate
cell attachment, proliferation, and differentiation. Nowadays, such traditional graft processing
methods such as solvent casting, particulate leaching, phase separation, lyophilization, gas foaming,
and electrospinning cannot precisely control uniformity, surface geometry, pore size distribution,
and interconnectivity of the scaffolds. Therefore, it is not easy for conventional techniques to create
patient-specific component scaffolds with various geometrical shapes. 3D printing, as alternatively
additive fabrication processes, is used for designing, and fabricating of scaffolds with designed shape,
interconnected porosity, and controlled chemistry and offers an innovative material processing method
to advance the manufacture artificial bone scaffolds based on the patient data and therefore the
treatment of bone injuries in a clinical application [14–16]. Combined with appropriate techniques and
innovative technologies, bone engineering uses a variety of biomaterials to mimic native bone structure.
The role of biomaterials which are used in tissue engineering is to facilitate and support functions
of the damaged site in the human body and to provide structure for cell specialization, migration,
and population [17]. The scaffold gives structural support for cell proliferation, maintenance of cell
function, and extracellular matrix (ECM) formation [18,19].
Although there are many studies concerning PCL/Gel/HA-based formulations, based on the
existing knowledge, this is the unique study reporting 3D printing results of PCL/GEL/HA and BC
containing PCL/GEL/HA. Incorporation of bacterial cellulose and HA with PCL/GEL was analyzed
by testing tensile strength and breaking elongation to determine how mechanically affected it was.
In-vitro experiments have proven the effect of bacterial cellulose and HA presence on PCL/GEL scaffold
for cell viability.
In this study, PCL/GEL/BC/HA scaffolds were manufactured using 3D printing. The FTIR analysis
was performed to understand the content of the materials. DSC thermogram was drawn to analyze
samples thermally. The tensile testing machine was used to analyze mechanically. Cell attachment
on the scaffold surfaces was visualized with optical microscopy and scanning electron microscopy
(SEM). To understand the toxic effect of 3D structures on cells, an in vitro study was performed with
osteoblast cells.
Polymers 2020, 12, 1962 3 of 14
2.1. Materials
D(+)-Glucose anhydrous for biochemistry (Mw = 180.16 g/mol, C6 H12 O6 ), disodium hydrogen
phosphate (Mw = 141.96 g/mol, Na2 HPO4 ), acetic acid (glacial) (100% purity, Mw = 60.05 g/mol,
CH3 COOH), sodium hydroxide (Mw = 40.00 g/mol, NaOH), sulfuric acid (95–97% purity,
Mw = 98.08 g/mol, H2 SO4 ), formic acid (98–100% purity, Mw = 46.03 g/mol molecular, CH2 O2 ),
and glycerol (Mw = 92.1 g/mol, C3 H8 O3 ) were purchased from Merck KGaA, Darmstadt, Germany.
Peptone from animal tissue from meat with suitability for cell and plant culture, citric acid (99% purity,
Mw = 192.12 g/mol, C6 H8 O7 ), gelatin from porcine skin (powder, gel strength ~300 g Bloom, Type A,
BioReagent, for electrophoresis, suitable for cell culture), polycaprolactone (PCL) with 80,000 average
Mn were bought from Sigma-Aldrich, St. Louis, MO, USA. Yeast extract and agar bacteriological were
purchased from Biolife, Italia. Hydroxyapatite (Mw = 502.31 g/mol) from was bought from Oerlikon
Metco, Wohlen, Switzerland.
2.2. Methods
Parameters Values
Number of Layers 10
Flow Rate (mL/h) 0.2
Needle Tip Outer Diameter (mm) 0.5
Platform Temperature (◦ C) 38
Room Temperature (◦ C) 25
Infill Rate (%) 50, 60, 70, and 80
of dimethylsulfoxide (DMSO). Plates were again incubated for 15 min at 37 ◦ C with 5% CO2 , and the
absorbance was measured using a microplate reader in 560 nm wavelength.
Morphological analyzes of the 3D printed scaffolds were characterized using a confocal microscope
(Zeiss Model LSM700, Zeiss, Oberkochen, Germany) and scanning electron microscopy (SEM,
EVO MA-10, Zeiss, Oberkochen, Germany). After 7 days of incubation, samples were fixed with 2.5%
glutaraldehyde (Sigma, St. Louis, MO, USA) for 2 h and then dehydrated through serial dilutions
of ethanol (30%, 50%, 70%, 90%, and 99%). Dried samples which were analyzed using SEM were
sputter-coated with gold (SC 7620 model, Quorum Technologies, Sacramento, CA, USA) for 90 s and
observed by SEM (EVO MA-10, Zeiss, Oberkochen, Germany) with an accelerating voltage of 10 kV.
After 7 days of incubation, the 3D printed scaffolds fixed with 4% formaldehyde for 1 h followed
by washing using PBS. The samples were permeabilized in 0.1% Triton X-100 in PBS for 30 min,
followed by washing with PBS. The samples were then stained with DAPI (1 µg/mL) for 40 min at room
temperature and again washed with PBS. The cell fluorescence was determined using a fluorescence
microscope with a 20×.
(C=O), again asymmetric COC stretching, asymmetric COC stretching, symmetric COC stretching,
respectively [26]. Gelatin showed various bands at ~3277.4 cm−1 which corresponded the N–H stretch
coupled with hydrogen bonding. The peak at ~2935.1 cm−1 is due to the alkenyl C–H stretching.
C=O stretching was observed at ~1628.6 cm−1 . Other peaks were found at ~1443.5 cm−1 (CH2 ),
~1234.2 cm−1 (NH), ~1079 (C–O stretching) (Figure 3 A(c)) [27]. The FTIR spectrum of the BC was given
in Figure 3A(d). There were detected broad absorption peaks for BC some of them are: ~3342 cm−1
(OH stretching), ~2896.6 cm−1 (CH stretching), ~1622.8 cm−1 (related to the bending mode of the
naturally absorbed water), ~14297.1 cm−1 (CH2 and COH bending inside of plane), ~664.4 cm−1 (C–OH
bending out of plane) [28]. Figure 3B showed the FTIR spectrums of the composites. In Figure 3B(a),
there were observed some shifts after the interaction between the PCL and GEL such as the peak for
pure PCL at 2940.9 cm−1 was shifted to 2923.6 cm−1 , another peak for pure GEL which is observed at
1519.6 cm−1 was shifted to 1526.4 cm−1 . The absorption peak for pure GEL at 1332.6 cm−1 was also
observed at PCL/GEL composite. There was found another difference that the peaks at 1079 cm−1
(pure GEL) and 1045 cm−1 (pure PCL), these peaks gave mean value at ~1044.3 cm−1 which can be
evidence of the interaction between the Gelatin and PCL polymers. By the addition of 0.25%BC
into PCL/GEL, BC peaks observed in the mixture at ~2865.7 and ~1530.2 cm−1 points and some
shifts were observed after the interaction (Figure 3B(b)). In Figure 3B(c), the FTIR spectrum of
PCL/GEL/BC/0.25%HA is shown. The specific GEL absorption peaks were observed at ~3278.4 and
~2942.8 cm−1 in the PCL/GEL/BC/0.25%HA spectrum. In addition, by the addition of 0.25%HA,
there were observed small shifts between the PCL/GEL/BC and PCL/GEL/BC/0.25%HA composites.
With the addition of 0.50%HA into the PCL/GEL/BC composite, there was not observed the sharp
difference between the spectrums. The peaks which were observed for the PCL/GEL/BC/0.25%HA
composite were seen in the spectrum of PCL/GEL/BC/0.50%HA composite (Figure 3B(d)).
Polymers 2020, 12, 1962 6 of 14
Figure1. 1. Mean
Figure Mean pore
pore size
sizeforfor(a)(a)
PCL/GEL,
PCL/GEL,(b) (b)
PCL/GEL/BC,
PCL/GEL/BC, (c) PCL/GEL/BC/0.25%HA, (d)
(c) PCL/GEL/BC/0.25%HA,
(d)PCL/GEL/BC/0.50%HA
PCL/GEL/BC/0.50%HAsolution
solution at at
50%, 60%,
50%, 70%,
60%, andand
70%, 80%80%
infill rate,rate,
infill respectively.
respectively.
Polymers 2020, 12, 1962 7 of 14
Figure 2. Cont.
Polymers 2020, 12, 1962 8 of 14
Polymers 2020, 12, 1962 8 of 14
i j
k l
the interaction (Figure 3B(b)). In Figure 3B(c), the FTIR spectrum of PCL/GEL/BC/0.25%HA is shown.
The specific GEL absorption peaks were observed at ~3278.4 and ~2942.8 cm−1 in the
PCL/GEL/BC/0.25%HA spectrum. In addition, by the addition of 0.25%HA, there were observed
small shifts between the PCL/GEL/BC and PCL/GEL/BC/0.25%HA composites. With the addition of
0.50%HA into the PCL/GEL/BC
Figure2.2. SEM
composite, there was not observed the sharp difference between the
Figure SEMimages
imagesof of
(a,i)(a,i)
PCL/GEL, (c,j) (c,j)
PCL/GEL, PCL/GEL/BC,
PCL/GEL/BC,(e,k) PCL/GEL/BC/0.25%HA, (g,l)
(e,k) PCL/GEL/BC/0.25%HA,
spectrums.
(g,l)
The peaks which
PCL/GEL/BC/0.50%HA
PCL/GEL/BC/0.50%HA
were
scaffolds observed
and and
scaffolds
for
porepore the
size size PCL/GEL/BC/0.25%HA
histiograms of (b)ofPCL/GEL,
histiograms
composite were
(d) PCL/GEL/BC,
(b) PCL/GEL, (f)
(d) PCL/GEL/BC,
seen in
the spectrum of PCL/GEL/BC/0.50%HA
(f)PCL/GEL/BC/0.25%HA
PCL/GEL/BC/0.25%HA and h)h)
and composite (Figure
PCL/GEL/BC/0.50%HA
PCL/GEL/BC/0.50%HA 3B(d)).
scaffolds.
scaffolds.
The functional groups related to pure polymers and their composites were identified by FTIR
spectroscopy. In Figure 3A, the FTIR spectrum of pure polymers and synthesized bacterial cellulose
is given with their functional groups. In Figure 3A(a), hydroxyapatite (HA) had main absorption
peaks at ~1087.7 cm−1 (PO43−, asymmetric stretching), ~1018.2 cm−1 (PO43−, asymmetric stretching),
~962.3 cm−1 (PO43−, symmetric stretching), ~628.7 cm−1 (OH bending), ~597.8 cm−1, and ~561.2 cm−1 is
due to the asymmetric bend of PO43− [24,25]. The spectrum of PCL (Figure 3A(b)) showed several
peaks around ~2940.9 cm−1, ~2865 cm−1, ~1720.2 cm−1, ~1293 cm−1, ~1238.1 cm−1, ~1164 cm−1 which were
associated with asymmetric CH2 stretching, symmetric CH2 stretching, carbonyl stretching (C=O),
again asymmetric COC stretching, asymmetric COC stretching, symmetric COC stretching,
respectively [26]. Gelatin showed various bands at ~3277.4 cm−1 which corresponded the N–H stretch
coupled with hydrogen bonding. The peak at ~2935.1 cm−1 is due to the alkenyl C–H stretching. C=O
stretching was observed at ~1628.6 cm−1. Other peaks were found at ~1443.5 cm−1 (CH2), ~1234.2 cm−1
(NH), ~1079 (C–O stretching) (Figure 3 A(c)) [27]. The FTIR spectrum of the BC was given in Figure
3A(d). There were detected broad absorption peaks for BC some of them are: ~3342 cm−1 (OH
stretching), ~2896.6 cm−1 (CH stretching), ~1622.8 cm−1 (related to the bending mode of the naturally
absorbed water), ~14297.1 cm−1 (CH2 and COH bending inside of plane), ~664.4 cm−1 (C–OH bending
out of plane) [28]. Figure 3B showed the FTIR spectrums of the composites. In Figure 3B(a), there
were observed some shifts after the interaction between the PCL and GEL such as the peak for pure
PCL at 2940.9
Figure
Figure 3.3.FTIRcm−1 was
FTIR shifted
spectrums
spectrums to
of 2923.6
of (A,a) (A,a) cm −1, another
pure peak
(A,b)for
hydroxyapatite,
pure hydroxyapatite, pure
(A,b)
pure GEL
PCL,pure which
pureis
PCL,
(A,c) observed
(A,c) pure
gelatin, at pure
1519.6
gelatin,
(A,d)
cmbacterial
−1 waspure
(A,d) shifted to 1526.4
bacterial cm −1. The
cellulose, absorption
(B,a) PCL/GEL, peak
(B,b)for pure GEL
PCL/GEL/BC, at 1332.6
(B,c)
cellulose, (B,a) PCL/GEL, (B,b) PCL/GEL/BC, (B,c) PCL/GEL/BC/0.25%HA, (B,d) cm −1 was also observed
PCL/GEL/BC/0.25%HA,
at PCL/GEL composite. There was found another difference that the peaks at 1079 cm−1 (pure GEL)
(B,d) PCL/GEL/BC/0.50%HA.
PCL/GEL/BC/0.50%HA.
and 1045 cm (pure PCL), these peaks gave mean value at ~1044.3 cm−1 which can be evidence of the
−1
DSC thermograms
interaction
DSC thermograms wereshown
between the Gelatin
were shown
and PCL for PCL/GEL,
forpolymers.
PCL/GEL, By the PCL/GEL/BC,
addition
PCL/GEL/BC, of 0.25%BC PCL/GEL/BC/0.25%HA,
into PCL/GEL, BCand
PCL/GEL/BC/0.25%HA,
and PCL/GEL/BC/0.50%HA in Figure 4. PCL has a melting temperature at approximate ◦ C.
peaks observed in the mixture at ~2865.7 and ~1530.2 cm points and some shifts were 58–6058–60
observed afterThe
−1
PCL/GEL/BC/0.50%HA in Figure 4. PCL has a melting ◦
temperature at approximate °C.
The decomposition temperature (Td ) of PCL is 350 C [29]. As shown in Figure 4, four endothermic
decomposition temperature (Td) of PCL is 350 °C [29]. As shown in Figure 4, four endothermic peaks
at approximate 60 °C observed which are related to melting temperature (Tm) of PCL [30]. It can be
observed that the scaffolds showed a degradation step in the range of 387–430 °C. The maximum
decomposition rate of 420 °C was observed for PCL/GEL/BC/0.50%HA. These conclusions agree with
the values which are reported in the literature [31–33]. In addition, endothermic peaks (Tm) at 61.60,
61.70, 62.04 and 63.54 °C were observed which are related to melting temperature of gelatin [34].
Figure 3. FTIR spectrums of (A,a) pure hydroxyapatite, (A,b) pure PCL, (A,c) pure gelatin, (A,d) pure
bacterial cellulose, (B,a) PCL/GEL, (B,b) PCL/GEL/BC, (B,c) PCL/GEL/BC/0.25%HA, (B,d)
PCL/GEL/BC/0.50%HA.
PCL/Gel
PCL/Gel/BC
PCL/Gel/BC/0.25%HA
PCL/Gel/BC/0.50%HA
200
1.Day
***
*** 4.Day
7.Day
% Viability according to TCP
150 **
100
*
***
50
0
PCL/GEL PCL/GEL/BC PCL/GEL/BC/0.25%HA PCL/GEL/BC/0.50%HA
It is clearly shown that in the case of scaffolds containing HA, the cell viability was found to be
significantly increased irrespective of their HA content when compared to PCL/GEL and PCL/GEL/BC
scaffolds. Furthermore, the addition of 0.25 wt % HA to PCL/GEL/BC showed excellent cell viability
during the 3 and 7 days of the incubation period.
Cell morphology on the 3D printed scaffolds was shown in Figure 6. Osteoblast cells were seeded
on scaffolds. After 7 days of cell culture, the morphological structures of cells adhesion to PCL/GEL
(Figure 6A), PCL/GEL/BC (Figure 6B), PCL/GEL/BC/0.25%HA (Figure 6C), and PCL/GEL/BC/0.50%HA
(Figure 6D) scaffolds were demonstrated by SEM analysis. The results clearly showed that osteoblast
cells tend to proliferate and adapt to the extracellular matrix on which they were cultured on the
scaffold. The printed composite scaffolds showed a more rounded and interconnected morphology.
The result clearly showed that culturing cells on PCL/Gel composite scaffold exhibited a spread shape
morphologies with a pseudopodia-like extended structures to the scaffolds. On 3D printed scaffolds,
osteoblast cells displayed extensive cytoplasmic dendritic structures (Figure 6A,B,D), similar to a
characteristic morphology of osteocytes. Cell adhesion on the 3D printed scaffolds was observed using
fluorescent staining with DAPI after 7 days of cell seeding (Figure 7). It was also recognized that the
osteoblast cells had an excellent cell attachment on the 3D printed scaffolds.
interconnected morphology. The result clearly showed that culturing cells on PCL/Gel composite
scaffold exhibited a spread shape morphologies with a pseudopodia-like extended structures to the
scaffolds. On 3D printed scaffolds, osteoblast cells displayed extensive cytoplasmic dendritic
structures (Figure 6A,B,D), similar to a characteristic morphology of osteocytes. Cell adhesion on the
3D printed scaffolds was observed using fluorescent staining with DAPI after 7 days of cell seeding
Polymers 2020, 12, 1962 11 of 14
(Figure 7). It was also recognized that the osteoblast cells had an excellent cell attachment on the 3D
printed scaffolds.
A B
C D
Figure 6. SEM images of human osteoblast cells (white arrow) and pseudopodia-like extended
Figure 6. SEM images of human osteoblast cells (white arrow) and pseudopodia-like extended
morphology (orange arrow) on (A) PCL/GEL, (B) PCL/GEL/BC, (C) PCL/GEL/BC/0.25%HA, (D)
morphology (orange arrow) on (A) PCL/GEL, (B) PCL/GEL/BC, (C) PCL/GEL/BC/0.25%HA,
PCL/GEL/BC/0.50%HA scaffolds (scale bar 2 µm).
(D) PCL/GEL/BC/0.50%HA
Polymers 2020, 12, 1962 scaffolds (scale bar 2 µm). 12 of 14
A B
C D
Figure
Figure 7. Fluorescence
7. Fluorescence microscopy
microscopy images
images of human
of human osteoblast
osteoblast cells oncells on (A) PCL/GEL,
(A) PCL/GEL, (B)
(B) PCL/GEL/BC,
PCL/GEL/BC, (C) PCL/GEL/BC/0.25%HA, (D) PCL/GEL/BC/0.50%HA scaffolds.
(C) PCL/GEL/BC/0.25%HA, (D) PCL/GEL/BC/0.50%HA scaffolds.
4. Conclusions
In this study, porous scaffolds were fabricated using 3D printing for four different composites
at four different infill rates from fifty to eighty percent. It was aimed to produce scaffolds with
ideal/optimal pore size and high uniformity ratio. All three-dimensional printed scaffolds which have
80% infill rate both have an ideal pore size for bone tissue engineering and have a uniformity ratio of
more than 90%. The composite’s tensile strength, although PCL/Gel/BC blends increased compared
to that of PCL/Gel/BC/HA blends, was considerably lower than that of the PCL/Gel. The
Polymers 2020, 12, 1962 12 of 14
4. Conclusions
In this study, porous scaffolds were fabricated using 3D printing for four different composites at
four different infill rates from fifty to eighty percent. It was aimed to produce scaffolds with ideal/optimal
pore size and high uniformity ratio. All three-dimensional printed scaffolds which have 80% infill
rate both have an ideal pore size for bone tissue engineering and have a uniformity ratio of more than
90%. The composite’s tensile strength, although PCL/Gel/BC blends increased compared to that of
PCL/Gel/BC/HA blends, was considerably lower than that of the PCL/Gel. The PCL/GEL/BC/0.25%HA
scaffold demonstrated good cell viability and cell adhesion when compared to PCL/GEL, PCL/GEL/BC
and PCL/GEL/BC/0.50%HA. Altogether, these results suggest that the prepared 3D composite scaffolds
have a great potential to develop better bone implants for biomedical applications.
Author Contributions: Conceptualization, A.M.C., S.U., A.S., F.N.O., M.S., N.E., O.G., and D.M.K.; data curation,
A.M.C., S.U., A.S.; formal analysis, S.U. and A.S.; funding acquisition, F.N.O.; investigation, A.M.C., S.U.,
A.S.; methodology, A.M.C., S.U., and A.S.; supervision, F.N.O., O.G., and D.M.K.; validation, A.M.C., S.U.;
writing—original draft, A.M.C., S.U.; writing—review and editing, A.M.C., S.U., A.S., F.N.O., O.G., and D.M.K.
All authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by Marmara University Scientific Research grant number FEN-C-YLP-121218-0616.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Langer, R. Biomaterials in drug delivery and tissue engineering: One laboratory’s experience. Acc. Chem. Res.
2000, 33, 94–101. [CrossRef] [PubMed]
2. Bonassar, L.J.; Vacanti, C.A. Tissue engineering: The first decade and beyond. J. Cell Biochem. 1998, 72, 297–303.
[CrossRef]
3. Atala, A. Tissue engineering and regenerative medicine. Rejuvenation Res. 2019, 7, 235–258. [CrossRef]
4. Ivkovic, A.; Marijanovic, I.; Hudetz, D.; Porter, R. Regenerative medicine and tissue engineering in orthopaedic
surgery. Regen. Orthop. 2011, 3, 923–944. [CrossRef]
5. Surmenev, R.A.; Shkarina, S.; Syromotina, D.S.; Melnik, E.V.; Shkarin, R.; Selezneva, I.I.; Ermakov, A.M.;
Ivlev, S.I.; Cecilia, A.; Weinhardt, V.; et al. Characterization of biomimetic silicate- and strontium-containing
hydroxyapatite microparticles embedded in biodegradable electrospun polycaprolactone sca ff olds for bone
regeneration. Eur. Polym. J. 2019, 113, 67–77. [CrossRef]
6. Noh, Y.K.; Costa, A.D.S.D.; Park, Y.S.; Du, P.; Kim, I.-H.; Park, K. Fabrication of bacterial cellulose-collagen
composite scaffolds and their osteogenic effect on human mesenchymal stem cells. Carbohydr. Polym. 2019,
219, 210–218. [CrossRef]
7. Zaborowska, M.; Bodin, A.; Bäckdahl, H.; Popp, J.; Goldstein, A.; Gatenholm, P. Microporous bacterial
cellulose as a potential scaffold for bone regeneration. Acta Biomater. 2010, 6, 2540–2547. [CrossRef]
8. Ramani, D.; Sastry, T.P. Bacterial cellulose-reinforced hydroxyapatite functionalized graphene oxide:
A potential osteoinductive composite. Cellulose 2014, 21, 3585–3595. [CrossRef]
9. Abdelraof, M.; Hasanin, M.S.; Farag, M.M.; Ahmed, H.Y. Green synthesis of bacterial cellulose/bioactive
glass nanocomposites: Effect of glass nanoparticles on cellulose yield, biocompatibility and antimicrobial
activity. Int. J. Biol. Macromol. 2019, 138, 975–985. [CrossRef]
10. Huang, Y.; Wang, J.; Yang, F.; Shao, Y.; Zhang, X.; Dai, K. Modification and evaluation of micro-nano structured
porous bacterial cellulose scaffold for bone tissue engineering. Mater. Sci. Eng. C 2017, 75, 1034–1041.
[CrossRef]
11. Yin, Y.; Ye, F.; Cui, J.; Zhang, F.; Li, X.; Yao, K. Preparation and characterization of macroporous
chitosan–gelatin/β-tricalcium phosphate composite scaffolds for bone tissue engineering. J. Biomed. Mater. Res.
2003, 67, 844–855. [CrossRef] [PubMed]
12. Su, K.; Wang, C. Recent advances in the use of gelatin in biomedical research. Biotechnol. Lett. 2015,
37, 2139–2145. [CrossRef]
13. Song, J.-H.; Kim, H.-E.; Kim, H.-W. Production of electrospun gelatin nanofiber by water-based co-solvent
approach. J. Mater. Sci. Mater. Med. 2008, 19, 95–102. [CrossRef] [PubMed]
Polymers 2020, 12, 1962 13 of 14
14. Ma, H.; Feng, C.; Chang, J.; Wu, C. 3D-printed bioceramic scaffolds: From bone tissue engineering to tumor
therapy. Acta Biomater. 2018, 79, 37–59. [CrossRef] [PubMed]
15. Zhang, L.; Yang, G.; Johnson, B.N.; Jia, X. Three-dimensional (3D) printed scaffold and material selection for
bone repair. Acta Biomater. 2019, 84, 16–33. [CrossRef] [PubMed]
16. Turnbull, G.; Clarke, J.; Picard, F.; Riches, P.; Jia, L.; Han, F.; Li, B.; Shu, W. 3D bioactive composite scaffolds
for bone tissue engineering. Bioact. Mater. 2018, 3, 278–314. [CrossRef] [PubMed]
17. Shrivats, A.R.; Mcdermott, M.C.; Hollinger, J.O. Bone tissue engineering: State of the union.
Drug Discov. Today 2014, 19, 781–786. [CrossRef]
18. Paula, A.; Madrid, M.; Paola, A.; Vrech, S.M.; Sanchez, M.A. Advances in additive manufacturing for bone
tissue engineering scaffolds. Mater. Sci. Eng. C 2019, 100, 631–644. [CrossRef]
19. Hutmacher, D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21, 2529–2543.
[CrossRef]
20. Hestrin, S.; Schramm, M. Synthesis of cellulose by Acetobacter xylinum: 2. Preparation of freeze-dried cells
capable of polymerizing glucose to cellulose. Biochem. J. 1953, 58, 345–352. [CrossRef]
21. Karageorgiou, V.; Kaplan, D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005,
26, 5474–5491. [CrossRef] [PubMed]
22. Cyster, L.A.; Grant, D.M.; Howdle, S.M.; Rose, F.R.A.J.; Irvine, D.J.; Freeman, D.; Scotchford, C.A.;
Shakesheff, K.M. The influence of dispersant concentration on the pore morphology of hydroxyapatite
ceramics for bone tissue engineering. Biomaterials 2005, 26, 697–702. [CrossRef]
23. Roosa, S.M.M.; Kemppainen, J.M.; Moffitt, E.N.; Krebsbach, P.H.; Hollister, S.J. The pore size of
polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J. Biomed.
Mater. Res. Part. A 2010, 92, 359–368. [CrossRef]
24. Andrea, P.; Sossa, F.; Giraldo, B.S.; Clemencia, B.; Garcia, G.; Parra, E.R.; Jose, P.; Arango, A. Comparative
study between natural and synthetic Hydroxyapatite: Structural, morphological and bioactivity properties.
Rev. Matér. 2018, 23. [CrossRef]
25. Koutsopoulos, S. Synthesis and characterization of hydroxyapatite crystals: A review study on the analytical
methods. J. Biomed. Mater. Res. 2002, 62, 600–612. [CrossRef]
26. Elzein, T.; Nasser-eddine, M.; Delaite, C.; Bistac, S.; Dumas, P. FTIR study of polycaprolactone chain
organization at interfaces. J. Colloid Interface Sci. 2004, 273, 381–387. [CrossRef]
27. Premlatha, T.S.; Kothai, S. Synthesis, Characterization and Antibacterial Activity of Gelatin-Herb
Nanocomposite. Asian J. Biomed. Pharm. Sci. 2015, 5, 2–4. [CrossRef]
28. Auta, R.; Adamus, G.; Kwiecien, M.; Radecka, I.; Hooley, P. Production and characterization of bacterial
cellulose before and after enzymatic hydrolysis. Afr. J. Biotechnol. 2017, 16, 470–482. [CrossRef]
29. Wang, F.; Shor, L.; Darling, A.; Khalil, S.; Sun, W.; Güçeri, S.; Lau, A. Precision extruding deposition and
characterization of cellular polycaprolactone tissue scaffolds. Rapid Prototyp. J. 2004, 10, 42–49. [CrossRef]
30. Ghorab, D.; Amin, M.; Khowessah, O. Colon-targeted celecoxib-loaded Eudragit S100-coated polycaprolactone
microparticles: Preparation, characterization and in vivo evaluation in rats. Drug Deliv. 2011, 18, 523–535.
[CrossRef]
31. Lozano-Sánchez, L.; Bagudanch, I.; Sustaita, A.O.; Iturbe-Ek, J.; Elizalde, L.E.; Garcia-Romeu, L.M.;
Elías-Zúñiga, A. Single-Point Incremental Forming of Two Biocompatible Polymers: An Insight into Their
Thermal and Structural Properties. Polymers 2018, 10, 391. [CrossRef]
32. Cervantes, A.L.; Lopez, I.D.; Sanchez, J.D.O.B.; Garcia, A.L.G. Effects of surface texturing on the performance
of biocompatible UHMWPE as a bearing material during in vitro lubricated sliding/rolling motion. J. Mech.
Behav. Biomed. Mater. 2013, 20, 45–53. [CrossRef] [PubMed]
33. Khan, R.A.; Parsons, A.J.; Jones, I.A.; Walker, G.S.; Rudd, C.D. Preparation and Characterization of Phosphate
Glass Fibers and Fabrication of Poly (caprolactone) Matrix Resorbable Composites. J. Reinf. Plast. Compos.
2010, 29, 1838–1850. [CrossRef]
34. Asma, C.; Meriem, E.; Mahmoud, B.; Djaafer, B. Physicochemical Characterization of Gelatin-GMC Composite
Edibles Films from Polyion-complex Hydrogels. J. Chil. Chem. Soc. 2014, 59, 2279–2283. [CrossRef]
35. Zhang, Y.; Ouyang, H.; Chwee, T.L.; Ramakrishna, S.; Huang, Z.M. Electrospinning of gelatin fibers and
gelatin/PCL composite fibrous scaffolds. J. Biomed. Mater. Res. 2005, 72, 156–165. [CrossRef]
Polymers 2020, 12, 1962 14 of 14
36. Kim, J.W.; Shin, K.H.; Koh, Y.H.; Hah, M.J.; Moon, J.; Kim, H.E. Production of poly(ε-caprolactone)/
hydroxyapatite composite scaffolds with a tailored macro/micro-porous structure, high mechanical properties,
and excellent bioactivity. Materials 2017, 10, 1123. [CrossRef]
37. Zhou, Y.G.; Zou, J.R.; Wu, H.H.; Xu, B.P. Balance between bonding and deposition during fused deposition
modeling of polycarbonate and acrylonitrile-butadiene-styrene composites. Polym. Compos. 2020, 41, 60–72.
[CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).